WHAT ARE CLINICAL TRIALS?
Clinical trials are used to show that an experimental medication works and is safe. Qualified doctors run clinical trials. They are responsible for the study-related care of the people that join.
Independent committees made up of medical and nonmedical people also watch over clinical trial to make sure that the people who join are told everything they need to know and are protected.
WHY PARTICIPATE IN CLINICAL TRIAL?
Millions of people enroll in clinical trials every year. The reasons why people choose to take part are as unique and varied as the people themselves. A clinical trial may offer the hope of choices. Some people enroll to help find a future treatment or for science. The reasons why you consider a clinical trial are yours alone. You should only decide once you have learned all about a clinical trial.
OUR CURRENT TRIALS:
- ELIXA Clinical Trial
- Lantu_L_05191 Clinical Trial
ELIXA Clinical Trial
What is ELIXA Clinical Trial?
ELIXA is a clinical trial being done to see if lowering the blood sugar with an experimental anti-diabetes medication will prevent future “cardiovascular events” such as heart attacks and strokes in people with type 2 diabetes who have already experienced a cardiovascular event. The experimental medication (em) will be compared to a placebo. Either em or placebo will be injected once a day using an injection pen.
This study if for people who have both diabetes and heart disease, and who have recently been in the hospital for a cardiovascular event such as heart attack or unstable angina. In total 6,000 people like you are being enrolled in approximately 50 countries.
People who enroll in ELIXA will receive all their study-related medical care and diabetes testing supplies for free. Also if you join you will get diet and exercise counseling. Maybe most important, you will be seen by an expert doctor who will closely watch your diabetes and heart disease.
Do I qualify for the ELIXA study?
You may be eligible for ELIXA if you:
- Are over age 30 years old
- Have type 2 diabetes or have been told you have high blood sugar level
- Were recently in the hospital for an acute coronary event (certain types of heart attacks or unstable angina)
- Able and willing to perform glucose self-monitoring using the sponsor-provided glucose meter and to complete the patient diary
Please contact us to get more information about this study
Lantu_L_05191 Clinical Trial
What is the Lantu_L_05191 Clinical Trial?
The purpose of this study is to evaluate which method patients prefer for administering their insulin Glardine. Two methods of insulin administration will be compared. In one method, insulin Glardine is measured from a vial (a small bottle) and administered with a syringe and needle. In the other method, insulin Glardine is administered with a pre-filled device for measuring and injecting insulin (also known as insulin pen). Participants in this study will have the opportunity to try both methods for 2 weeks each in random order (by chance – similar to a flip of a coin) and fill out a questionnaire to evaluate each method. Participants will then continue to receive their insulin Glardine either by vial and syringe or by pen for additional 36 weeks. During this time fasting blood sugar and HbA1C (glycosylated hemoglobin, which is a test to measure the average blood glucose level over the past 3 months) will be measures periodically to determine if one method is better than the other for keeping blood glucose under control.
If you decide to enroll in LANTU_L_05191, you will be seeing the doctor regularly. You will receive study medication and all diabetes testing supplies for free. You will also receive important counseling about healthy diet and exercise. For someone with type 2 diabetes, this advice will be extremely important.
You may be eligible for Lantu_L_05191 if you:
- Between ages 18-85
- Have Type 2 Diabetes for at least 3 months
- Currently being treated with any combination of 2 or 3 oral antidiabetic drugs at a stable dose for the preceding 3 months
- Did not receive treatment with Insulin in the past year but whose physician has decided that basal insulin is appropriate
- Able and willing to perform glucose self-monitoring using the sponsor-provided glucose meter and to complete the patient diary
Please contact us to get more information about this study
